Episode 343

Closing the GLP-1 Post-Prescription Gap, One Shot at a Time with Aja Beckett

Jul 27, 2026

28:29

Episode Description

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE

Episode Overview:

Millions of people are prescribed GLP-1 medications and then left entirely on their own, navigating confusion, stigma, and unanswered questions with no structured support in sight.

Aja Beckett, Founder and CEO of Shotsy, is closing that post-prescription gap from the inside out.

As both an iOS engineer and a GLP-1 user herself, Aja brings a rare combination of technical depth and lived experience to one of healthcare's most urgent challenges.

Having built her career across Apple, CNN, TED, and The New York Times, she now channels that expertise into Shotsy, the number one companion app helping users turn every injection into a step toward lasting change.

Join us to discover how community-driven innovation, empathy, and thoughtful technology are making the GLP-1 journey feel less lonely and more empowering. Let's go!

Episode Highlights:

Aja lost 90 pounds on GLP-1 medication, inspiring her to build Shotsy for others on the same journey.
Shotsy filled a real gap, gaining 50 beta testers in 90 minutes and earning revenue on day one.
The app normalizes the GLP-1 experience through celebratory design, reducing shame and loneliness for users.
Community-driven beta testing serves as Shotsy's product team, shaping features for a truly global audience.
Aja envisions Shotsy as the go-to companion for the full GLP-1 journey, prioritizing support over clinical replacement.

About our Guest:

Aja brings the rare perspective of being both an iOS engineer and a GLP-1 user, now leading one of the fastest-growing health apps in the space. Her journey in tech spans some of the industry's most influential companies, including Apple, CNN, TED, and The Athletic/The New York Times.

As a founder, Aja created Civil, a groundbreaking platform that garnered attention from major publications like WIRED, The Guardian, and TechCrunch. Her approach to product development emphasizes community-driven innovation and user-centric design.

Today, she's channeling her expertise into Shotsy, revolutionizing how people manage their GLP-1 medication journey through thoughtful technology and data-driven insights.

Links Supporting This Episode: